Skip to main content
Top

Current Treatment Options in Oncology

Issue 10/2017

Content (6 Articles)

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Rectal Cancer in Asian vs. Western Countries: Why the Variation in Incidence?

Yanhong Deng

Genitourinary Cancers (W Oh and M Galsky, Section Editors)

Management of Atypical Renal Cell Carcinomas

Bobby C. Liaw, Reza Mehrazin, Charles Baker, John P. Sfakianos, Che-Kai Tsao

Gynecologic Cancers (LA Cantrell, Section Editor)

Fertility Sparing Strategies in Patients Affected by Placental Site Trophoblastic Tumor

Benito Chiofalo, Vittorio Palmara, Antonio Simone Laganà, Onofrio Triolo, Salvatore Giovanni Vitale, Francesca Conway, Giuseppe Santoro

Gynecologic Cancers (LA Cantrell, Section Editor)

Sentinel Lymph Node Biopsy in Endometrial Cancer: a New Standard of Care?

Stephanie A. Sullivan, Emma C. Rossi

Gynecologic Cancers (LA Cantrell, Section Editor)

Immunotherapy in Gynecologic Cancers: Are We There Yet?

Janelle B. Pakish, Amir A. Jazaeri

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine